Björn Holzhauer

2 ta ish

Novartis (Switzerland)

1. Cardiovascular outcomes at different on-treatment blood pressures in the hypertensive patients of the VALUE trial

   Giuseppe Mancia, Sverre E. Kjeldsen, Dion Zappe +5

   Maqola20153 iqtibos

   ABIABI:AkademIndex/2026.other.295794

2. No evidence for a J-shaped curve in treated hypertensive patients with increased cardiovascular risk: The VALUE trial

   Sverre E. Kjeldsen, Eivind Berge, Sripal Bangalore +8

   Maqola20152 iqtibos

   ABIABI:AkademIndex/2026.other.295654